Latest Teriparatide Stories
A medication already approved to build bone mass in patients with osteoporosis also builds cartilage around joints and could potentially be repurposed to treat millions of people suffering from arthritis.
WEST CHESTER, Pa. and INDIANAPOLIS, June 9, 2011 /PRNewswire/ -- Synthes, Inc.
CAMBRIDGE, Mass. and ST. PAUL, Minn., May 24, 2011 /PRNewswire/ -- Radius Health, Inc.
CAMBRIDGE, Mass., May 24, 2011 /PRNewswire/ -- Radius Health, Inc.
INDIANAPOLIS, March 17, 2011 /PRNewswire/ -- Eli Lilly and Company (NYSE: LLY) announced today that patients should not use the alcohol prep pads made by the Triad Group that are contained in the black starter kits for ForteoÂ® [teriparatide (rDNA origin) injection] in the United States.
The American Association of Clinical Endocrinologists (AACE) has released new medical guidelines for the diagnosis and treatment of postmenopausal osteoporosis.
A drug marketed to grow bone in osteoporosis patients also works to heal bone wounds in gum disease patients.
Forteo, a drug produced by Eli Lilly and Co. and used for osteoporosis, has been found to be able to re-grow bone in jaws damaged by severe bone-destroying conditions called osteonecrosis and periodontitis, doctors reported on Saturday.